fracture, fall history, thyroid disease, hyperparathyroidism, rheumatoid arthritis, malabsorption, chronic liver disease, and inflammatory bowel disease (Figure 1 1 1 1 We conditionally recommend treatment for those at moderate or very high risk of fracture with oral or IV BP, โก PTH/PTHrP, ยง or DEN ยง# PTH/PTHrP Agonists (TER, ABL, Anti-RANKL, DEN) We conditionally recommend PTH/PTHrP over antiresorptives in patients at very high risk of fracture. We conditionally recommend DEN ยง# or PTH/PTHrP